Norvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Ritonavir.
| Product ID | 0074-2340_ff281f75-bfea-433a-8d28-d33cdb898f00 |
| NDC | 0074-2340 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Norvir |
| Generic Name | Ritonavir |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-08-16 |
| Marketing Category | NDA / |
| Application Number | NDA022417 |
| Labeler Name | AbbVie Inc. |
| Substance Name | RITONAVIR |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2022-08-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-1940 | Norvir | Ritonavir |
| 0074-2340 | Norvir | Ritonavir |
| 0074-3333 | Norvir | Ritonavir |
| 0074-3399 | Norvir | Ritonavir |
| 50090-1162 | Norvir | Ritonavir |
| 53808-1119 | Norvir | Ritonavir |
| 67296-1234 | Norvir | Norvir |
| 0054-0407 | Ritonavir | Ritonavir |
| 31722-597 | Ritonavir | Ritonavir |
| 60687-364 | Ritonavir | Ritonavir |
| 60687-420 | Ritonavir | Ritonavir |
| 65162-061 | Ritonavir | Ritonavir |
| 65862-687 | Ritonavir | Ritonavir |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NORVIR 74655713 2001944 Live/Registered |
ABBVIE INC. 1995-04-04 |